Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.

about

Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.

Item

http://www.wikidata.org/entity/Q37691036

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.

@en

Determination of VEGFR-2

@nl

type

Item

label

Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.

@en

Determination of VEGFR-2

@nl

prefLabel

Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.

@en

Determination of VEGFR-2

@nl

P1476

Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders

@en

P2093

Adrian Săftoiu

http://www.w3.org/2001/XMLSchema#string

Anca Ştefania Enescu

http://www.w3.org/2001/XMLSchema#string

Aurelia Enescu

http://www.w3.org/2001/XMLSchema#string

Dragoş Alexandru

http://www.w3.org/2001/XMLSchema#string

Elena Mădălina Dumitrescu

http://www.w3.org/2001/XMLSchema#string

Florin Petrescu

http://www.w3.org/2001/XMLSchema#string

Ileana Octavia Petrescu

http://www.w3.org/2001/XMLSchema#string

Ioana Streaţă

http://www.w3.org/2001/XMLSchema#string

Lidia Boldeanu

http://www.w3.org/2001/XMLSchema#string

Maria Forţofoiu

http://www.w3.org/2001/XMLSchema#string

P2860

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor

Pathways for aberrant angiogenesis in pancreatic cancer

Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy.

Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis.

VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma.

EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification.

P31

scholarly article

P356

10.3390/IJMS18020439

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28218664

http://www.w3.org/2001/XMLSchema#string

P932

5343973

http://www.w3.org/2001/XMLSchema#string